[Molecular size heterogeneity of SPan-1 antigen and co-expression with Lewis phenotype determinants in sera from gastrointestinal malignant diseases].

Article

[Molecular size heterogeneity of SPan-1 antigen and co-expression with Lewis phenotype determinants in sera from gastrointestinal malignant diseases].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology - 1 Jul 1992

Chung Y S, Yamashita Y, Sawada T, Kondo Y, Kim K, Inui M, Onoda N, Kubo T, Nakata B, Sowa M

Abstract excerpt

Molecular size of SPan-1 antigen and co-expression between SPan-1 epitope and Lewis phenotype determinants (LPD) on the same molecule in sera from patients with pancreatic, gastric and colon cancer and in culture medium from cancer cell line were studied. Column chromatography study on culture medium and sera showed that SPan-1 immunoreactivity was found in the void volume region as single major peak, or followed...

Topics

Antigens, Neoplasm
Epitopes
Gastrointestinal Neoplasms
Humans
Lewis X Antigen
Molecular Structure
Phenotype

Identifiers

PMID: 1380997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-1380997-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

[Molecular size heterogeneity of SPan-1 antigen and co-expression with Lewis phenotype determinants in sera from gastrointestinal malignant diseases].PMID 1380997Read

Epitope analysis of SPan-1 and DUPAN-2 using synthesized glycoconjugates sialyllact-N-fucopentaose II and sialyllact-N-tetraose.Semantic proximity Read

Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer.Semantic proximity Read

[Recent advances of pancreatic cancer].Semantic proximity Read

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic CancerSemantic proximity Read

[The molecular pathology of pancreatic cancers].Semantic proximity Read

[Molecular mechanism in pathogenesis of pancreatic cancers: P53 oncosuppressive gene].Semantic proximity Read

[Tumor antigens].Semantic proximity Read

Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.Semantic proximity Read